Prof Enrique Fisman
Tel-Aviv University, Israel
Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.
Since the American Heart Association stated in 1999 that 'diabetes is a cardiovascular disease', many revolutionary events took place in the rapidly evolving field of cardiovascular diabetology. The initial 'bridal' between heart diseases and diabetes is at present a vast and complex interdisciplinary texture which includes innovative biotechnological approaches, such as genomics, proteomics, metabolomics, molecular biometrics, bioinformatics, customized therapies and various additional sophisticated practices. Our journal endeavors to be a harbinger of these fascinating advances.
Enrique Fisman graduated with a medical degree from Buenos Aires University, Argentina. Subsequently, he achieved the degree of Academic Cardiologist at the same university and worked for seven years at Carlos G. Durand Hospital in Buenos Aires. His research interests encompass numerous fields of cardiology, with emphasis on Doppler and exercise echocardiography, hemodynamics of estrogens, diagnostic expediency of dynamic and isometric stress testing, sports cardiology, epidemiology, hypertension, and cardiovascular pharmacology. Since 1998, he has been involved in the research of several clinical topics regarding the diabetes/cardiovascular interrelationship at Sheba Medical Center, Tel-Hashomer, Israel. Since 2002, he has served as an Editor-in-Chief of Cardiovascular Diabetology. He is a Professor of Cardiology at Tel-Aviv University and Honorary Professor of Cardiology at University del Salvador, Buenos Aires.
